| Financial Year |
March 31 2023 |
| Monetary Funds |
18,697,627,049.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,907,471,382.00 |
| Accounts Receivable |
42,767,772,355.00 |
| Advances to Suppliers |
8,346,573,579.00 |
| Other Receivables |
2,827,925,569.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,119,758,960.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
805,239,871.00 |
| Other Current Assets |
4,412,285,187.00 |
| Total Current Assets |
90,017,140,836.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,489,020,741.00 |
| Long-term Equity Investment |
24,050,521,439.00 |
| Investment Properties |
626,410,473.00 |
| Fixed Assetes |
287,654,005,057.00 |
| Under-construction Projects |
47,112,483,666.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,651,781,634.00 |
| R&D expenses |
-- |
| Goodwill |
11,503,934,548.00 |
| Long-Term Deferred and Prepaid Expenses |
264,432,207.00 |
| Deferred Income Tax Assets |
6,271,939,918.00 |
| Other Non-Current Assets |
9,431,750,131.00 |
| Sub-Total of Non-Current Assets |
417,980,075,961.00 |
| Total Assets |
507,997,216,797.00 |
| Short-Term Loans |
65,933,246,505.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,755,304,655.00 |
| Accounts Payable |
20,222,246,908.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,174,769,727.00 |
| Taxes Payable |
1,527,396,735.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,995,128,670.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,399,201,998.00 |
| Other Current Liabilities |
6,957,566,835.00 |
| Sub-Total of Current Liabilities |
147,096,706,764.00 |
| Long-term Loans |
162,064,546,753.00 |
| Bonds Payable |
39,012,740,851.00 |
| Long-Term Accounts Payable |
944,355,063.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
40,224,495.00 |
| Deferred Income Tax Liabilities |
1,292,469,333.00 |
| Other Non-Current Liabilities |
4,330,355,471.00 |
| Sub-Total of Non-Current Liabilities |
215,082,061,204.00 |
| Total Liabilities |
362,178,767,968.00 |
| Paid-In Capital(Or Share Stock) |
15,698,093,359.00 |
| Capital Surplus |
16,618,831,574.00 |
| Surplus Reserve |
8,186,274,738.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,287,945,689.00 |
| Minority Stockholder's Interest |
18,239,671,659.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
127,578,777,170.00 |
| Owner's Equity（Stockholder's Equity） |
145,818,448,829.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
507,997,216,797.00 |
